Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.54 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.42 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.42 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19593402 | 0.97 | EPHX1 (0.50) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL7749273 | 0.89 | EPHX1 (0.75) | EPHX1ALDH1A1EPHX2 | |
| SCHEMBL14643386 | 0.89 | EPHX1 (0.75) | EPHX1ALDH1A1EPHX2 | |
| SCHEMBL9811711 | 0.89 | EPHX1 (0.75) | EPHX1ALDH1A1EPHX2 | |
| SCHEMBL7749192 | 0.89 | EPHX1 (0.75) | EPHX1ALDH1A1EPHX2 | |
| SCHEMBL10587839 | 0.89 | EPHX1 (0.45) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL18641844 | 0.89 | EPHX1 (0.75) | EPHX1ALDH1A1EPHX2 | |
| SCHEMBL660087 | 0.87 | PAOX (0.56) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL23735553 | 0.85 | KEAP1 (0.52) | EPHX1PRMT1KDM4EMAPK1HIF1A | |
| SCHEMBL1395514 | 0.85 | EPHX1 (0.71) | EPHX1ALDH1A1SMN1; SMN2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0323590-A2 | Carbazoyl derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1989-07-12 | — | — | EP | claimed |
| EP-4685195-A1 | DEGRADABLE CROSSLINKING AGENT | NAGASE CHEMTEX CORPORATION (JP) | 2026-01-28 | — | — | EP | disclosed |
| WO-2025028636-A1 | DEGRADABLE CROSSLINKING AGENT | ナガセケムテックス株式会社 | 2025-02-06 | — | — | WO | disclosed |
| WO-2025028637-A1 | DEGRADABLE COMPOUND | ナガセケムテックス株式会社 | 2025-02-06 | — | — | WO | disclosed |
| WO-2024195687-A1 | DEGRADABLE CROSSLINKING AGENT | ナガセケムテックス株式会社 | 2024-09-26 | — | — | WO | disclosed |
| CN-113929866-B | Modified resin and resin composition | 旭化成株式会社 | 2023-07-07 | — | — | CN | disclosed |
| CN-111205424-B | Modified resin and resin composition | 旭化成株式会社 | 2022-04-08 | — | — | CN | disclosed |
| CN-113929866-A | Modified resin and resin composition | 旭化成株式会社 | 2022-01-14 | — | — | CN | disclosed |
| US-20210393850-A1 | BIOINKS | UNIVERSITEIT MAASTRICHT (NL) | 2021-12-23 | — | — | US | disclosed |
| EP-3877452-A1 | BIOINKS | Universiteit Maastricht (NL) | 2021-09-15 | — | — | EP | disclosed |
| CN-108264631-A | Curing agent and the resin combination for having used the curing agent | 协立化学产业株式会社 | 2018-07-10 | — | — | CN | disclosed |
| WO-2014010446-A1 | CURING AGENT AND RESIN COMPOSITION USING SAME | 協立化学産業株式会社 (JP) | 2014-01-16 | — | — | WO | disclosed |
| US-20110028719-A1 | SCREENING METHODS FOR AMYLOID BETA MODULATORS | WARATAH PHARMACEUTICALS INC. (CA) | 2011-02-03 | — | — | US | disclosed |
| US-20110028719-A1 | SCREENING METHODS FOR AMYLOID BETA MODULATORS | WARATAH PHARMACEUTICALS INC. (CA) | 2011-02-03 | — | — | US | disclosed |
| US-20100075043-A1 | INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20090035491-A1 | Ink-Jet Recording Material | MITSUBISHI PAPER MILLS LIMITED (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20080299318-A1 | INK-JET RECORDING MATERIAL AND METHOD FOR PREPARING THE SAME | SAKAGUCHI HIROSHI | 2008-12-04 | — | — | US | disclosed |
| US-20070128349-A1 | Process for preparing ink-jet recording material | MITSUBISHI PAPER MILLS LIMITED (JP) | 2007-06-07 | — | — | US | disclosed |
| EP-1491351-B1 | Ink-jet recording material and method for preparing the same | MITSUBISHI PAPER MILLS LTD (JP) | 2006-04-12 | — | — | EP | disclosed |
| US-20040265514-A1 | Ink-jet recording material and method for preparing the same | MITSUBISHI PAPER MILLS LIMITED (JP) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028719-A1 | SCREENING METHODS FOR AMYLOID BETA MODULATORS | APP, BACE1, IAPP | EPHX1 2529/4885PRMT1 3185/4885KDM4E 4738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.